Stockscreener 앱 받기
1.09
5.83%
0.06
시간 외 거래:
1.09
전일 마감가:
$1.03
열려 있는:
$1.0209
하루 거래량:
61,876
Relative Volume:
0.85
시가총액:
$16.64M
수익:
$48.43M
순이익/손실:
$-11.04M
주가수익비율:
-1.6269
EPS:
-0.67
순현금흐름:
$-7.00M
1주 성능:
+9.00%
1개월 성능:
+10.10%
6개월 성능:
-31.45%
1년 성능:
-62.67%
1일 변동 폭
$1.02
$1.12
1주일 범위
$0.98
$1.1299
52주 변동 폭
$0.782
$3.25
Iridex Corp Stock (IRIX) Company Profile
명칭
Iridex Corp
전화
(650) 940-4700
주소
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
IRIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
1.09 | 16.64M | 48.43M | -11.04M | -7.00M | -0.67 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2017-11-03 | 재개 | ROTH Capital | Buy |
| 2016-12-21 | 개시 | ROTH Capital | Buy |
| 2016-01-26 | 개시 | Singular Research | Buy |
| 2007-01-03 | 개시 | First Albany | Buy |
Iridex Corp 주식(IRIX)의 최신 뉴스
Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025 - Yahoo Finance
IRIDEX Corp Board Reshuffles Following Novel Transaction - Investing.com Australia
Iridex to Host Strategic Vision Call on April 16, 2025 - Yahoo Finance
IRIDEX Corp Board Reshuffles Following Novel Transaction By Investing.com - Investing.com South Africa
IRIDEX Director Resigns to Comply with Rights Agreement - Investing.com
Reviewing IRIDEX (NASDAQ:IRIX) & CeriBell (NASDAQ:CBLL) - Defense World
StockNews.com Begins Coverage on IRIDEX (NASDAQ:IRIX) - Defense World
IRIDEX Corporation (NASDAQ:IRIX) Q4 2024 Earnings Call Transcript - MSN
Iridex: Q4 Earnings Snapshot - MySA
IRIDEX Corp (IRIX) Q4 2024 Earnings Call Highlights: Strategic Investments and Revenue Growth ... - Yahoo
IRIDEX Corp (IRIX) Q4 2024 Earnings Call Highlights: Strategic Investments and Revenue Growth Amidst Challenges - GuruFocus
Iridex Corporation Reports Improved Financial Performance - TipRanks
IRIDEX earnings matched, revenue fell short of estimates - Investing.com
Earnings call transcript: IRIDEX Q4 2024 sees aftermarket stock surge - Investing.com
IRIDEX Corp Q4 2024 Earnings: EPS Meets Estimate at -$0.05, Reve - GuruFocus
IRIDEX Earnings Results: $IRIX Reports Quarterly Earnings - Nasdaq
Iridex Reports Fourth Quarter and Full Year 2024 Financial Results - Yahoo Finance
Earnings Preview For Iridex - Benzinga
IRIDEX Earnings Preview: Recent $IRIX Insider Trading, Hedge Fund Activity, and More - Nasdaq
IRIDEX (NASDAQ:IRIX) Shares Cross Below 200-Day Moving Average – Should You Sell? - Defense World
IRIDEX (NASDAQ:IRIX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Iridex secures $10 million investment for growth initiatives By Investing.com - Investing.com
Iridex Corporation Closes $10 Million Strategic Investment with Novel Inspiration International Co., Ltd. - Nasdaq
Iridex Announces Strategic Investment in the Company - GlobeNewswire
Iridex Stock: Volatility Persists Amid Stable Fundamentals - Sharewise
Iridex addresses recent stock volatility - Investing.com
Iridex Comments on Recent Stock Price Volatility - Yahoo Finance
Iridex Corporation to Announce Q4 and Full Year 2024 Financial Results on March 27, 2025 - Nasdaq
Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025 - GlobeNewswire Inc.
IRIDEX (NASDAQ:IRIX) Coverage Initiated by Analysts at StockNews.com - Defense World
IRIDEX (NASDAQ:IRIX) Coverage Initiated at StockNews.com - Defense World
StockNews.com Initiates Coverage on IRIDEX (NASDAQ:IRIX) - Defense World
Iridex reports steady Q4 sales, eyes profitability in 2025 - Investing.com
Iridex Reports Mixed Q4 Results: Revenue Up, Achieves Positive EBITDA Amid Strategic Review - StockTitan
IRIDEX (NASDAQ:IRIX) Stock Passes Below 200 Day Moving Average – Time to Sell? - Defense World
IRIDEX (NASDAQ:IRIX) Now Covered by Analysts at StockNews.com - Defense World
IRIDEX (NASDAQ:IRIX) Now Covered by StockNews.com - Defense World
Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management - Yahoo Finance
Medical Lasers Market Focused Insights 2024-2029: Mergers, - GlobeNewswire
Veterinary Eye Care Market to Grow by USD 1.05 Billion (2024-2028), Report on AI-Powered Market Evolution and Rising Pet OwnershipTechnavio - The Malaysian Reserve
United States Retinal Surgery Devices Market - GlobeNewswire
IRIX Stock Surges Over 6% Amidst Medical Device Sector Decline - GuruFocus.com
Advancing Healthcare Tech: Medical Lasers Market Report 2024 - WhaTech
IRIDEX Corporation (NASDAQ:IRIX) Q3 2024 Earnings Call Transcript - MSN
Iridex's Glaucoma Treatment Exempt from New Medicare Reimbursement Limits | IRIX Stock News - StockTitan
Iridex Corp (IRIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.32%
자본화:
|
볼륨(24시간):